KevinGreggBillingsleyMDMBA
General Surgery • New Haven, CTHepatobiliary Surgery, Pancreas, Surgical Oncology (Other than Breast)
Chief Medical Officer, Yale Cancer Center Professor of Surgery, Division of Surgical Oncology School of Medicine Yale School of Medicine
Dr. Billingsley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
20 York St. North Pavilion
Smilow Cancer Hospital, 15 th Floor, Suite 300
New Haven, CT 06510Phone+1 203-200-3168- Is this information wrong?
Summary
- I am gastrointestinal surgical oncologist with a primary focus on the multidisciplinary treatment of patients with tumors of the liver, bile ducts and pancreas.
In addition to my clinical practice I am the CMO of the Yale Cancer Center
My research involves clinical and outcome studies in the hepatobiliary and pancreatic cancer. I have a particular interest in developing novel approaches to the treatment of liver metastases.
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Complex General Surgical Oncology, 1996 - 1998
Oregon Health & Science UniversityResidency, Surgery, 1989 - 1996
National Cancer InstituteFellowship, Senior Staff Fellow, Surgery Branch, 1992 - 1994
Johns Hopkins University School of MedicineClass of 1989
Certifications & Licensure
OR State Medical License 1990 - 2025
CT State Medical License 2019 - 2024
WA State Medical License 1998 - 2021
MD State Medical License 1992 - 1994- American Board of Surgery Surgery
Awards, Honors, & Recognition
- James IV Fellow James IV Association, 2007
- America's Top Doctors Castle Connolly, 2011-2014
- Portland Monthly Magazine Castle Connolly, 2011
- Join now to see all
Clinical Trials
- Surgery With or Without Radiofrequency Ablation Followed by Irinotecan in Treating Patients With Colorectal Cancer That is Metastatic to the Liver Start of enrollment: 2001 May 01
- S0408: Capecitabine, Oxaliplatin, and Bevacizumab in Pts Undergoing Surgery for Liver Mets From Colorectal Cancer Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- Impact of COVID-19 on the gastrointestinal surgical oncology patient population.Baylee F Bakkila, Victoria A Marks, Daniel Kerekes, John W Kunstman, Ronald R Salem, Kevin G Billingsley, Nita Ahuja, Maxwell Laurans, Kelly Olino, Sajid A Khan> ;Heliyon. 2023 Aug 1
- Hepatopancreatobiliary malignancies: time to treatment matters.Daniel M Kerekes, Alexander E Frey, Baylee F Bakkila, Caroline H Johnson, Robert D Becher, Kevin G Billingsley, Sajid A Khan> ;Journal of Gastrointestinal Oncology. 2023 Apr 29
- 7 citationsHepatectomy is associated with improved oncologic outcomes in recurrent colorectal liver metastases: A propensity-matched analysis.Thomas L Sutton, Liam H Wong, Brett S Walker, Elizabeth N Dewey, Robert Eil, Charles D Lopez, Adel Kardosh, Emerson Y Chen, Flavio G Rocha, Kevin G Billingsley, Skye C...> ;Surgery. 2023 Jun 1
- Join now to see all
Press Mentions
Patrick a. Kenney, MD, Appointed Medical Director, Smilow Cancer Hospital Care Center at Greenwich HospitalJanuary 13th, 2023- Coping with Cancer and COVID During the HolidaysDecember 25th, 2021
- How Patients with Cancer Can Navigate COVID-19 for the HolidaysDecember 20th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Hospital Affiliations
Yale-New Haven HospitalNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
